About Repertoire Genesis
We have a world's best unbiased gene analysis method of T cell receptor (TCR) and B cell receptor (BCR). Our technology makes it possible to evaluate treatment effects of cancer immune cell therapy, bone marrow transplantation, or immune check point inhibitors. Our platform technology can also be used for development of promising advanced medical technologies such as TCR gene therapy, CAR-T therapy, and antibody drug development.
State of Ownership
Business Development Associate Director, University of Michigan
Business Development Executive, Nature Publishing Group, Springer Nature
Sales Account Executive, Springer Nature
Managing Director, Thoroughly Good Consulting
CEO & Co-Founder, Zapnito